Publications

Wikoff D, Haws L, Ring C, Budinsky R. 2019. Application of qualitative and quantitative uncertainty assessment tools in developing ranges of plausible toxicity values for 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin. J Appl Toxicol 39(9):1293-1310; doi: 10.1002/jat.3814.

Beckett EM, Cyrs WD, Abelmann A, Monnot AD, Gaffney SH, Finley BL. 2019. Derivation of an occupational exposure limit for diacetyl using dose-response data from chronic animal inhalation exposure study. J Appl Toxicol 39(5):688–701.

Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019. Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period. Inhal Toxicol 31(6):213–223.

Wikoff D, Erranguntla N, Lewis J, Foreman J. A fit-for-purpose framework for use of systematic methods in risk assessment. Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

Urban J, Wikoff D, Haws L. Three-tiered approach to integrating evidence streams assessing gestational trichloroethylene exposure and congenital heart defects (TCE-CHD). Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine. Washington, DC, June 2019.

Borghoff S, Fitch S, Britt J, Franke K, Wikoff D. Application of the EFSA/ECHA endocrine disruption guidance as a framework for evidence integration in a weight-of-evidence (WoE) analysis for oxybenzone (BP-3). Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

Kreider ML, Hynds ES, Panko JM. Evaluation of tire and road wear particles (TRWP) in air in Delhi, India. Poster at Society of Toxicology 58th Annual Meeting, Baltimore, MD, March 2019.

Brixner D, Ermakova A, Xiong Y, Sieradzan R, Sacks NC, Cyr PL, Taylor S. 2019. Clinical and economic outcomes of patients with type 2 diabetes on multiple daily injections of basal-bolus insulin (MDI) therapy: A retrospective cohort study. Clin Therapeut 41(2):303–313; doi: 10.1016/j.clinthera.2018.12.014.

Heintz MM, Kumar R, Rutledge M, Baldwin WS. 2019. Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis. J Nutr Biochem 70(August):125–137; doi: 10.1016/j.jnutbio.2019.05.004.

Heintz MM, Kumar R, Baldwin WS. Cyp2b-null male mice are susceptible to high-fat diet-induced obesity due to changes in PUFA metabolism and response to hepatic lipids as measured by RNAseq. International Congress on Toxicology (ICTXV), Honolulu, HI, July 2019.

Olack E, Heintz MM, Baldwin WS. Human CYP2B6 is an anti-obesity enzyme involved in unsaturated fatty acid metabolism. International Congress on Toxicology (ICTXV), Honolulu, HI, July 2019.

Heintz MM, Sengupta N, Noorai R, Baldwin WS. Triclosan exposure represses development and alters sphingomyelin metabolism in Daphnia magna as determined by RNA-seq and lipidomics. 20^th Pollutant Responses in Marine Organisms, PRIMO20, Charleston, SC, May 2019.

Heintz MM, McRee R, Baldwin WS. The role of Cyp2b in diet-induced nonalcoholic steatohepatitis. Invited speaker: Clemson University Environmental Toxicology Program Seminar, Clemson, SC, April 2019.

Zucker RM, Rogers JM. 2019. Confocal laser scanning microscopy of morphology and apoptosis in organogenesis-stage mouse embryos. Meth Mol Biol 1965:297–311; doi: 10.1007/978-1-4939-9182-2_20.

Choksi NY, Truax J, Layton A, Matheson J, Mattie D, Varney T, et al. 2019. United States regulatory requirements for skin and eye irritation testing. Cutan Ocul Toxicol 38(2):141–155; doi: 10.1080/15569527.2018.1540494.

Rogers JM, Watanabe M. 2019. Editorial: Special issue on “Developmental effects of smoking, vaping, and cannabis use.” Birth Defects Res 111(17):1245–1247; doi: 10.1002/bdr2.1596.

Rogers JM. 2019. Smoking and pregnancy: Epigenetics and the developmental origins of the metabolic syndrome. Birth Defects Res 111(17):1259–1269; doi: 10.1002/bdr2.1550.

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, LA, May 2019.

Fryzek J, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.

Bylsma LC, Levin-Sparenberg E, Lowe K, Sangare L, Fryzek J, Alexander DD. Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer (MCRC) patients: A systematic literature review and meta-analysis. Poster presented as part of a Spotlight Poster Session at the International Society for Pharmacoepidemiology, Philadelphia, PA, August 2019.